188 related articles for article (PubMed ID: 21261593)
1. Molecular determinants of selective agonist and antagonist binding to the histamine H₄ receptor.
Istyastono EP; de Graaf C; de Esch IJ; Leurs R
Curr Top Med Chem; 2011; 11(6):661-79. PubMed ID: 21261593
[TBL] [Abstract][Full Text] [Related]
2. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.
Savall BM; Edwards JP; Venable JD; Buzard DJ; Thurmond R; Hack M; McGovern P
Bioorg Med Chem Lett; 2010 Jun; 20(11):3367-71. PubMed ID: 20452213
[TBL] [Abstract][Full Text] [Related]
3. Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs.
Strasser A; Wittmann HJ; Buschauer A; Schneider EH; Seifert R
Trends Pharmacol Sci; 2013 Jan; 34(1):13-32. PubMed ID: 23228711
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.
Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R
J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553
[TBL] [Abstract][Full Text] [Related]
5. Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor.
Kiss R; Noszál B; Rácz A; Falus A; Eros D; Keseru GM
Eur J Med Chem; 2008 May; 43(5):1059-70. PubMed ID: 17900762
[TBL] [Abstract][Full Text] [Related]
6. Molecular pharmacology of histamine H4 receptors.
Nijmeijer S; de Graaf C; Leurs R; Vischer HF
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2089-106. PubMed ID: 22652766
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
[TBL] [Abstract][Full Text] [Related]
8. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical stimulatory effects of the "standard" histamine H4-receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity.
Seifert R; Schneider EH; Dove S; Brunskole I; Neumann D; Strasser A; Buschauer A
Mol Pharmacol; 2011 Apr; 79(4):631-8. PubMed ID: 21266488
[TBL] [Abstract][Full Text] [Related]
11. Major advances in the development of histamine H4 receptor ligands.
Smits RA; Leurs R; de Esch IJ
Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
[TBL] [Abstract][Full Text] [Related]
12. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus.
Dunford PJ; Williams KN; Desai PJ; Karlsson L; McQueen D; Thurmond RL
J Allergy Clin Immunol; 2007 Jan; 119(1):176-83. PubMed ID: 17208599
[TBL] [Abstract][Full Text] [Related]
13. Histamine receptor subtypes: a century of rational drug design.
Walter M; Stark H
Front Biosci (Schol Ed); 2012 Jan; 4(2):461-88. PubMed ID: 22202071
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
15. Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators.
Tichenor MS; Thurmond RL; Venable JD; Savall BM
J Med Chem; 2015 Sep; 58(18):7119-27. PubMed ID: 25993395
[TBL] [Abstract][Full Text] [Related]
16. Profiling of histamine H4 receptor agonists in native human monocytes.
Gschwandtner M; Koether B; Werfel T; Stark H; Gutzmer R
Br J Pharmacol; 2013 Sep; 170(1):136-43. PubMed ID: 23638754
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
Schneider EH; Strasser A; Thurmond RL; Seifert R
J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
[TBL] [Abstract][Full Text] [Related]
18. Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations.
Jongejan A; Lim HD; Smits RA; de Esch IJ; Haaksma E; Leurs R
J Chem Inf Model; 2008 Jul; 48(7):1455-63. PubMed ID: 18553960
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
